Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Innovotech Inc V.IOT

Innovotech Inc. is a Canadian biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.


TSXV:IOT - Post by User

Bullboard Posts
Post by AlfredFettucineon Mar 19, 2015 10:23am
66 Views
Post# 23538020

Need more of this...

Need more of this...
As of 11:59pm ET March 18th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 21/15 Jan 16/15 Muhs, Dr. Wolfgang Direct Ownership Common Shares 10 - Acquisition in the public market 10,000 $0.020
Dec 17/14 Dec 17/14 Timourian, James Gregory Direct Ownership Common Shares 10 - Acquisition in the public market 116,000 $0.015
Dec 5/14 Dec 3/14 Timourian, James Gregory Direct Ownership Common Shares 10 - Acquisition in the public market 150,000 $0.010
Dec 2/14 Nov 28/14 Timourian, James Gregory Direct Ownership Common Shares 10 - Acquisition in the public market 3,000 $0.010
Oct 6/14 May 20/14 Christensen, Thomas Bruce Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report    

Bullboard Posts